These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 21881850
21. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis. Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL. Biochem J; 2006 Jan 01; 393(Pt 1):255-65. PubMed ID: 16173915 [Abstract] [Full Text] [Related]
22. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Cardiovasc Res; 2006 Jan 01; 69(1):36-45. PubMed ID: 16324688 [Abstract] [Full Text] [Related]
23. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL. Zeya B, Arjuman A, Chandra NC. Biochemistry; 2016 Aug 16; 55(32):4437-44. PubMed ID: 27419271 [Abstract] [Full Text] [Related]
24. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis]. Morawietz H. Dtsch Med Wochenschr; 2010 Feb 16; 135(7):308-12. PubMed ID: 20146162 [Abstract] [Full Text] [Related]
25. Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Aramaki Y, Mitsuoka H, Toyohara M, Jinnai T, Kanatani K, Nakajima K, Mukai E, Yamada Y, Kita T, Inagaki N, Kume N. Atherosclerosis; 2008 Jun 16; 198(2):272-9. PubMed ID: 18282574 [Abstract] [Full Text] [Related]
26. Association of angiotensin II receptor 1 and lectin-like oxidized low-density lipoprotein receptor-1 mediates the cardiac hypertrophy induced by oxidized low-density lipoprotein. Zhao Y, Li Y, Ning X, Chen K, Zhang S. Biochem Biophys Res Commun; 2017 Aug 12; 490(1):55-61. PubMed ID: 28595908 [Abstract] [Full Text] [Related]
27. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL. Am J Med Sci; 2011 Aug 12; 342(2):135-42. PubMed ID: 21747278 [Abstract] [Full Text] [Related]
28. LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains. Wang X, Ding Z, Lin J, Guo Z, Mehta JL. Biochem Biophys Res Commun; 2015 Nov 06; 467(1):135-9. PubMed ID: 26393906 [Abstract] [Full Text] [Related]
29. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation. Wang Z, Chen J, Zeng Z, Zhang Q, Du G, Guo X, Wei Y. Mol Med; 2022 Mar 02; 28(1):26. PubMed ID: 35236285 [Abstract] [Full Text] [Related]
30. Role of Ox-LDL/LOX-1/NF-κB signaling pathway in regulation of atherosclerotic plaque growth by testosterone in male rabbits. Li S, Guo Y, Zhu P, Yang T. Vascul Pharmacol; 2013 Mar 02; 59(5-6):131-7. PubMed ID: 23022624 [Abstract] [Full Text] [Related]
31. Lectin-like oxidized low density lipoprotein receptor 1-deficient mice show resistance to instability-induced osteoarthritis. Hashimoto K, Mori S, Oda Y, Nakano A, Sawamura T, Akagi M. Scand J Rheumatol; 2016 Oct 02; 45(5):412-22. PubMed ID: 26901593 [Abstract] [Full Text] [Related]